Zydus Lifesciences Ltd successfully completes USFDA inspection at Moraiya facility

The USFDA conducted an inspection at the manufacturing facility of Zydus Lifesciences Limited located at Moraiya, Ahmedabad from 23rd to 27th January, 2023. The inspection was a Pre-Approval Inspection (PAI) for Transdermal Patch products. The inspection concluded with NIL observations.

Shares of Cadila Healthcare Limited was last trading in BSE at Rs. 426.10 as compared to the previous close of Rs. 437.10. The total number of shares traded during the day was 21613 in over 1132 trades.

The stock hit an intraday high of Rs. 440.00 and intraday low of 425.05. The net turnover during the day was Rs. 9262457.00.

Source : Equity Bulls

Keywords

ZydusLifesciences INE010B01027 Moraiya Inspection USFDA NILObservation